Marker Therapeutics logo

Marker Therapeutics Share Price Today (NASDAQ: MRKR)

Marker Therapeutics share price is $1.65 & ₹142.01 as on 15 Jun 2025, 2.30 'hrs' IST

$1.65

-0.04

(-2.37%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Marker Therapeutics share price in Dollar and Rupees. Guide to invest in Marker Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Marker Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Marker Therapeutics share price movements

  • Today's Low: $1.58
    Today's High: $1.67

    Day's Volatility :5.39%

  • 52 Weeks Low: $0.95
    52 Weeks High: $5.99

    52 Weeks Volatility :84.14%

Marker Therapeutics (MRKR) Returns

PeriodMarker Therapeutics IncIndex (Russel 2000)
3 Months
28.91%
0.0%
6 Months
-60.05%
0.0%
1 Year
-65.48%
0.0%
3 Years
-38.87%
2.2%

Marker Therapeutics (MRKR) Key Statistics

in dollars & INR

Previous Close
$1.69
Open
$1.67
Today's High
$1.67
Today's Low
$1.58
Market Capitalization
$19.1M
Today's Volume
$169.9K
52 Week High
$5.99
52 Week Low
$0.95
Revenue TTM
$5.7M
EBITDA
$-11.8M
Earnings Per Share (EPS)
$-1.19
Profit Margin
-224.45%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-97.3%

How to invest in Marker Therapeutics Stock (MRKR) from India?

It is very easy for Indian residents to invest directly in Marker Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Marker Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Marker Therapeutics or MRKR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Marker Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Marker Therapeutics shares which would translate to 0.522 fractional shares of Marker Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Marker Therapeutics, in just a few clicks!

Returns in Marker Therapeutics (MRKR) for Indian investors in Rupees

The Marker Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Marker Therapeutics investment value today

Current value as on today

₹37,557

Returns

₹62,443

(-62.44%)

Returns from Marker Therapeutics Stock

₹65,481 (-65.48%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Marker Therapeutics (MRKR)

29%

Period: May 15, 2025 to Jun 14, 2025. Change in 30 Days versus previous period

Search interest for Marker Therapeutics Stock from India on INDmoney has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Marker Therapeutics

  • NEA Management Company, LLC

    14.37%

  • Blue Owl Capital Holdings LP

    4.90%

  • Hudson Bay Capital Management LP

    4.42%

  • Aisling Capital Management LP

    2.88%

  • Vanguard Group Inc

    2.43%

  • Alyeska Investment Group, L.P.

    2.31%

Analyst Recommendation on Marker Therapeutics

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Marker Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Marker Therapeutics Stock (MRKR)

What analysts predicted

Upside of 263.64%

Target:

$6.00

Current:

$1.65

Insights on Marker Therapeutics Stock (Ticker Symbol: MRKR)

  • Price Movement

    In the last 1 month, MRKR stock has moved up by 46.0%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 2.25M → 349.10K (in $), with an average decrease of 84.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -2.19M → -4.44M (in $), with an average decrease of 29.1% per quarter
  • MRKR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 91.7% return, outperforming this stock by 152.1%
  • MRKR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 127.0% return, outperforming this stock by 165.9%
  • Price to Sales

    ForMRKR every $1 of sales, investors are willing to pay $2.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.8 for every $1 of sales.

Marker Therapeutics Technicals Summary

Sell

Neutral

Buy

Marker Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Marker Therapeutics (MRKR) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Marker Therapeutics Inc logo
48.65%
-60.05%
-65.48%
-38.87%
-92.47%
Regeneron Pharmaceuticals, Inc. logo
-11.02%
-27.05%
-49.42%
-5.02%
-10.81%
Beone Medicines Ltd logo
18.08%
52.93%
69.2%
101.57%
55.67%
Vertex Pharmaceuticals Incorporated logo
3.86%
-2.68%
-3.83%
81.53%
66.4%
Alnylam Pharmaceuticals, Inc. logo
7.76%
26.01%
95.45%
128.04%
132.45%

About Marker Therapeutics

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Organization
Marker Therapeutics
Employees
5
CEO
Dr. Juan F. Vera M.D.
Industry
Consumer Services

Management People of Marker Therapeutics

NameTitle
Dr. Juan F. Vera M.D.
Co-Founder, CEO, President, Treasurer, Secretary & Director
Ms. Elizabeth Donnelly
Director of Administration
Dr. Maria-Bernadette Madel Ph.D.
Director of Corporate Operations & External Communications
Mr. Edmund Cheung
Vice President of Human Resources
Patricia Allison
Head of Clinical Operations
Ms. Mary Newman Ph.D.
Head of Regulatory Affairs

Important FAQs about investing in MRKR Stock from India :

Can Indians buy Marker Therapeutics shares?

Yes, Indians can invest in the Marker Therapeutics (MRKR) from India.

With INDmoney, you can buy Marker Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Marker Therapeutics at zero transaction cost.

How can I buy Marker Therapeutics shares from India?

It is very easy to buy Marker Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Marker Therapeutics (MRKR) be purchased?

Yes, you can buy fractional shares of Marker Therapeutics with INDmoney app.

What are the documents required to start investing in Marker Therapeutics stocks?

To start investing in Marker Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Marker Therapeutics share price today?

Marker Therapeutics share price today stands at $1.65, Open: $1.67 ; Previous Close: $1.69 ; High: $1.67 ; Low: $1.58 ; 52 Week High: $5.99 ; 52 Week Low: $0.95.

The stock opens at $1.67, after a closing price of $1.69. The stock reached a daily high of $1.67 and a low of $1.58, with a 52-week high of $5.99 and a 52-week low of $0.95.

What are today’s High and Low prices of Marker Therapeutics Stock (MRKR)?

Today’s highest price of Marker Therapeutics (MRKR) is $1.67.

Today’s lowest price of Marker Therapeutics (MRKR) is $1.58.

What is the 52 Week High and Low Range of Marker Therapeutics Stock (MRKR)?

  • 52 Week High

    $5.99

  • 52 Week Low

    $0.95

What are the historical returns of Marker Therapeutics (MRKR)?

  • 1 Month Returns

    48.65%

  • 3 Months Returns

    -60.05%

  • 1 Year Returns

    -65.48%

  • 5 Years Returns

    -92.47%

What is today's market capitalisation of Marker Therapeutics?

Today's market capitalisation of Marker Therapeutics MRKR is 19.1M

Who is the Chief Executive Officer (CEO) of Marker Therapeutics ?

Dr. Juan F. Vera M.D. is the current Chief Executive Officer (CEO) of Marker Therapeutics.